source
- Legend Biotech CEO Ying Huang resigns, Carvykti head Max Gelman appointed interim chiefLegend Biotech announced that its chief executive officer, Ying Huang, has stepped down after serving in the role since November 2020. Huang's resignation was reported on Friday, marking the end o…
- Upcoming Q2 earnings from Moderna, AstraZeneca, GSK and others highlighted in weekly pharma previewThe Endpoints Weekly newsletter signals a busy earnings week for major pharmaceutical companies, with Q2 results slated from Moderna, AstraZeneca, GSK, Bristol Myers Squibb and several others. It…